Keyphrases
Cancer Xenograft
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
Ovarian Cancer
100%
Positron Emission Tomography
100%
18F-FLT
100%
Human Ovary
100%
Belinostat
100%
Treatment Group
42%
FDG Uptake
28%
Antitumor Activity
14%
Tracer Uptake
14%
2-deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography
14%
Positron Emission tomography-CT
14%
Small Animal Positron Emission Tomography
14%
Antitumor Effect
14%
18F-fluorothymidine
14%
Clinical Trials
14%
Tumor Growth
14%
Non-invasive Assessment
14%
Glucose Uptake
14%
In Vivo Uptake
14%
Histone Deacetylase Inhibitor (HDACi)
14%
In Vitro Tumor Models
14%
In Vivo Model
14%
Cell Proliferation
14%
A2780
14%
Tumor Size
14%
Treatment Initiation
14%
Twice Daily
14%
SUVmax
14%
Model Trial
14%
SUVmean
14%
Tumor
14%
Medicine and Dentistry
Fluorodeoxyglucose F 18
100%
Tumor Xenograft
100%
positron emission tomographic scan
100%
Ovarian Cancer
100%
Belinostat
100%
Fluorine-18
100%
Neoplasm
37%
Treatment Group
37%
Biological Marker
12%
Tumor Model
12%
Antineoplastic Activity
12%
Tumor Progression
12%
Histone Deacetylase Inhibitor
12%
Radioactive Tracer
12%
Clinical Trial
12%
Glucose Uptake
12%
Cell Proliferation
12%